Impact of neoadjuvant androgen ablation and other factors on late toxicity following external beam prostate radiation

Abstract

Purpose/Objective: 1.To evaluate the late toxicity profile of prostate cancer patients treated with external beam radiotherapy (EBRT).2.To investigate possible risk factors for late toxicity, and to determine if neoadjuvant androgen ablation (NAA) was a factor.